mecamylamine has been researched along with Arterial Occlusive Diseases in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brezenoff, HE | 1 |
| Carney, K | 1 |
| Buccafusco, JJ | 1 |
1 other study available for mecamylamine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Potentiation of the carotid artery occlusion reflex by a cholinergic system in the posterior hypothalamic nucleus.
Topics: Acetylcholine; Animals; Arterial Occlusive Diseases; Atropine; Blood Pressure; Carotid Artery Diseas | 1982 |